Canoo $200 million at-the-market offering
The stock offering is SEC-registered
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Vaccitech $75 million at-the-market offering
The ADSs are listed on the Nasdaq Global Market
RxSight $50 million at-the-market offering
The stock is listed on the Nasdaq Global Market
TransMedics Group $150 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Exelon $1 billion at-the-market offering
Exelon may enter into forward sale transactions under the at-the-market program
Allakos $75 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Legend Biotech $403 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Bally’s cash tender offer for stock
The company’s shares are traded on the NYSE
Revolution Medicines $264.5 million follow-on offering
The shares are listed on Nasdaq
Akeso HK$582 million share placement
We advised Akeso in the placement of new shares